PHILADELPHIA: Exciting times are ahead for Malaysia when one of the top Asian biopharmaceutical giants Biocon Ltd begins operations in the country next year.
Malaysia Biotechnology Corp (Biotech Corp) biomedical section senior vice-president Jay Padasian said it had taken about two years to convince the company to set up its integrated insulin plant in Malaysia.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
